Aprea Therapeutics, Inc.
APRE
$0.79
-$0.04-5.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.23% | -33.89% | 17.39% | 8.23% | 17.64% |
| Total Depreciation and Amortization | 5.56% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.28% | -40.43% | 31.32% | -28.03% | -2.64% |
| Change in Net Operating Assets | -52.22% | 164.74% | -106.33% | -412.18% | -150.32% |
| Cash from Operations | -18.94% | 6.91% | 6.62% | -1.29% | 13.78% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -98.58% | 733.05% | 1,022.35% | -6.10% | 575.34% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -413.55% | -27.71% | -2,036.21% | -16.78% | -338.24% |
| Cash from Financing | -105.60% | 801.29% | 973.37% | -7.01% | 589.78% |
| Foreign Exchange rate Adjustments | -133.33% | -123.08% | 316.67% | -123.08% | 85.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -116.42% | 3,514.69% | 131.33% | -2.57% | 23.24% |